0KF3.L
Palatin Technologies, Inc., a biopharmaceutical company, develops targeted receptor-specific therapeutics for the treatment of various diseases in the United States. The company's lead product is Vyleesi, a melanocortin receptor (MCr) agonist for the treatment of premenopausal women with hypoactive sexual desire disorder. It is also developing oral PL8177, a selective MC1r agonist peptide that has completed Phase I clinical trial for the treatment of inflammatory bowel diseases. In addition, the company engages in the development of PL9643, a peptide melanocortin agonist active at multiple MCrs, including MC1r and MC5r for anti-inflammatory ocular indications, such as dry eye disease; and me...[Read more]
Industry
Medical - Pharmaceuticals
IPO Date
2018-01-29
Stock Exchange
LSE
Ticker
0KF3.L
According to Palatin Technologies, Inc.’s latest financial reports and current stock price. The company's current Enterprise Value is 596.99M. This represents a change of 6.23% compared to the average of 9.44M of the last 4 quarters.
The mean historical Enterprise Value of Palatin Technologies, Inc. over the last ten years is 67.09M. The current 596.99M Enterprise Value has changed 88.88% with respect to the historical average. Over the past ten years (40 quarters), 0KF3.L's Enterprise Value was at its highest in in the June 2019 quarter at 210.92M. The Enterprise Value was at its lowest in in the June 2025 quarter at -2341265.72.
Average
67.09M
Median
45.59M
Minimum
-2341265.72
Maximum
183.18M
Discovering the peaks and valleys of Palatin Technologies, Inc. Enterprise Value, unveiling quarterly and yearly fluctuations to gain insights into the company’s financial performance and market dynamics, offering valuable data for investors and analysts alike.
Maximum Annual Increase = 202.27%
Maximum Annual Enterprise Value = 183.18M
Minimum Annual Increase = -112.72%
Minimum Annual Enterprise Value = -2341265.72
| Year | Enterprise Value | Change |
|---|---|---|
| 2025 | -2341265.72 | -112.72% |
| 2024 | 18.40M | 15.50% |
| 2023 | 15.93M | -58.10% |
| 2022 | 38.02M | -55.53% |
| 2021 | 85.50M | 124.40% |
| 2020 | 38.10M | -79.20% |
| 2019 | 183.18M | 14.18% |
| 2018 | 160.44M | 202.27% |
| 2017 | 53.08M | -34.14% |
| 2016 | 80.60M | -10.70% |
The current Enterprise Value of Palatin Technologies, Inc. (0KF3.L) is greater than its 3-year, greater than its 5-year, and greater than its 10-year historical averages
3-year avg
10.66M
5-year avg
31.10M
10-year avg
67.09M
Palatin Technologies, Inc.’s Enterprise Value is greater than Unity Biotechnology, Inc. (18.05M), greater than Endo International plc (-939048027.00), less than Invitae Corporation (1.50B), greater than VivoSim Labs, Inc. (-2182528.00), less than Imunon, Inc. (1.11B), greater than Accelerate Diagnostics, Inc. (52.34M), greater than DMK Pharmaceuticals Corporation (-737792.00),
| Company | Enterprise Value | Market cap |
|---|---|---|
| 18.05M | N/A | |
| -939048027.00 | N/A | |
| 1.50B | N/A | |
| -2182528.00 | N/A | |
| 1.11B | N/A | |
| 52.34M | N/A | |
| -737792.00 | N/A |
One of the best ways to find valuable stocks to invest in is to build a custom made screener in your Excel or Google Sheets spreadsheet. This allows you to compare thousands of companies like Palatin Technologies, Inc. using the financials and key metrics that matter to you in a single view.
The easiest way to set this up is to use the Wisesheets add-on and set your spreadsheet like this:
Covering all these metrics from financial, data, dividend data, key metrics and more you can get all the data you want for over 50+ exchanges worldwide.
Get your free trial here.
The easiest way to analyze a company like Palatin Technologies, Inc. or any others is to create a spreadsheet model that automatically retrieves all of the stock data you need.
Using Wisesheets you can set up a spreadsheet model like this with simple spreadsheet formulas. If you change the ticker you can get all of the data automatically updated for you.
Whether you need live data, historical price data, financials, dividend data, key metrics, analyst estimates, or anything else...Wisesheets has you covered.
What is the Enterprise Value?
How can you use the Enterprise Value?
What is Palatin Technologies, Inc.'s Enterprise Value?
What is the highest Enterprise Value for Palatin Technologies, Inc. (0KF3.L)?
What is the 3-year average Enterprise Value for Palatin Technologies, Inc. (0KF3.L)?
What is the 5-year average Enterprise Value for Palatin Technologies, Inc. (0KF3.L)?
How does the current Enterprise Value for Palatin Technologies, Inc. (0KF3.L) compare to its historical average?